Yes and no.
The guidance and associated enforcement affect providers who serve Medicare and Medicaid populations. But the guidance established by the OIG is still a good framework, regardless of payer source. And most commercial health plans have a government arm anyway like Medicare Advantage, which means everyone should be paying attention to these practices.